- Home
- CMCL vs CSTL Comparison
CMCL vs CSTL Comparison
Compare CMCL & CSTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMCL
- CSTL
- Stock Information
- Founded
- CMCL 1992
- CSTL 2007
- Country
- CMCL Jersey
- CSTL United States
- Employees
- CMCL N/A
- CSTL N/A
- Industry
- CMCL Precious Metals
- CSTL Medical Specialities
- Sector
- CMCL Basic Materials
- CSTL Health Care
- Exchange
- CMCL Nasdaq
- CSTL Nasdaq
- Market Cap
- CMCL 586.0M
- CSTL 697.9M
- IPO Year
- CMCL N/A
- CSTL 2019
- Fundamental
- Price
- CMCL $31.96
- CSTL $22.75
- Analyst Decision
- CMCL Strong Buy
- CSTL Strong Buy
- Analyst Count
- CMCL 1
- CSTL 6
- Target Price
- CMCL $28.00
- CSTL $37.67
- AVG Volume (30 Days)
- CMCL 285.4K
- CSTL 449.5K
- Earning Date
- CMCL 11-10-2025
- CSTL 11-03-2025
- Dividend Yield
- CMCL 1.76%
- CSTL N/A
- EPS Growth
- CMCL 432.25
- CSTL N/A
- EPS
- CMCL 1.92
- CSTL N/A
- Revenue
- CMCL $204,738,000.00
- CSTL $346,269,000.00
- Revenue This Year
- CMCL $41.68
- CSTL N/A
- Revenue Next Year
- CMCL N/A
- CSTL N/A
- P/E Ratio
- CMCL $16.25
- CSTL N/A
- Revenue Growth
- CMCL 28.06
- CSTL 20.40
- 52 Week Low
- CMCL $8.81
- CSTL $14.59
- 52 Week High
- CMCL $33.50
- CSTL $35.84
- Technical
- Relative Strength Index (RSI)
- CMCL 67.89
- CSTL 57.06
- Support Level
- CMCL $30.01
- CSTL $21.28
- Resistance Level
- CMCL $32.45
- CSTL $24.74
- Average True Range (ATR)
- CMCL 1.52
- CSTL 1.06
- MACD
- CMCL 0.20
- CSTL -0.28
- Stochastic Oscillator
- CMCL 81.62
- CSTL 42.77
About CMCL Caledonia Mining Corporation Plc
Caledonia Mining Corp PLC is a gold exploration, development, and mining company. The company's segment includes Blanket, South Africa, Bilboes Oxide mine, and E&E projects. The company generates the majority of its revenue from the Blanket project. The Blanket Mine is located in the south-west of Zimbabwe and operates at a depth of approximately 750 meters below the surface. The company's project includes Maligreen and Motapa.
About CSTL Castle Biosciences Inc.
Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. It also provides DecisionDx-UM, a risk stratification GEP test. The company also offers its products to the skin cancer and gastroenterology markets.